Catalyst Biosciences

Catalyst Biosciences

Catalyst Biosciences is a pharmaceutical company developing products to address hemophilia founded in 1997 by Jack Nguyen, Charles S. Craik, Christopher Thanos and Sandra Waugh Ruggles.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

December 3, 2008

Catalyst Biosciences raises a $40,000,000 series C round from HealthCare Ventures, Novartis Venture Fund and Morgenthaler Ventures.

February 9, 2006

Catalyst Biosciences raises a $30,000,000 series B round from HealthCare Ventures, Novartis Venture Fund and Morgenthaler Ventures.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Brajesh Kumar

Employee

David L Sloane

Employee

Elena Kren

Employee

Jacob Esparza

Employee

Jeff Landau

Employee

Lianne Gong

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
June 10, 2020
BioSpace
Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company developing novel subcutaneous (SQ) therapies for hemophilia and other bleeding disorders, today announced completion of its Phase 1 MAA-102 study for Marzeptacog alfa (activated) (MarzAA). The results support the use of SQ MarzAA to treat episodic bleeding. The company is on track to enroll the first patient in its Phase 3 registration trial evaluating the effic
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.